FDA Advisory Committee Recommends Lorcaserin for Obesity

Weight Loss Methods
A United States Food and Drug Administration (FDA) advisory committee recommended the approval of lorcaserin for the treatment of obesity. It was the second time the drug has gone before the advisory committee. In 2010, lorcaserin received a negative review because of concerns about it causing cancer. New followup information was submitted by the drug's manufacturer Arena Pharmaceuticals, and the FDA determined that the risk of tumors was "negligible." (more…)
Read More